The construction of hybridomas producing monoclonal antibodies for new, more specific diagnostic kits for the detection of colon cancer and some air allergens.
The project addresses the need for improved toxicity assays for better risk assessment to reduce the number of animals used to test toxins and toxic effects. These assays will be developed as kits for commercial availability.
A novel platform for the sustained intracellular delivery of therapeutic molecules.
The objective is to design and develop a histamine h3 receptor inverse agonist as a novel type of drug for use in the treatment of alzheimer's disease, obesity and/or epilepsy.
The aim is to obtain scientific and technological knowledge to develop a generic sterilisation and operation cassette for endoscopic instruments. Research targets: materials, configurations, construction, cleaning tubes, etc.
Development of new monoclonal antibodies against signal transducer and transcription activator "stati" protein and its endogenous inhibitor "socs3" protein. Construction of kit for detection of hla-g antigens.
The aim is to launch a new therapeutic method for sports medicine using a combination of new combined laser therapeutic device with adequate therapies and limited quantities of corresponding drugs.
Development of a natural component based on clays, diatomite and seaweeds which will replace the current growth promoters and the fight against mycotoxicosis in animal feed.
Production of recombinant allergens and secretory iga in the milk of transgenic rabbits. These compounds will be used for clinical trials to assess their efficiency as a treatment for allergies.
Research on innovative hrs-pharma tech. For drug development, based on rapid high resolution screening (hrs) of mixtures with thousands of compounds, resulting in more and higher quality drug candidates and allowing research into 'awkward' pharmaceutical targets.